Astera Labs (NASDAQ:ALAB – Get Free Report) released its quarterly earnings results on Tuesday. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07, FiscalAI reports. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same period last year, the business posted $0.33 earnings per share. The company’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs updated its Q2 2026 guidance to 0.680-0.700 EPS.
Here are the key takeaways from Astera Labs’ conference call:
- Astera Labs reported strong Q1 results with $308.4 million in revenue (up 14% sequential, 93% YoY), non‑GAAP EPS of $0.61, roughly $1.18 billion in cash, and Q2 guidance of $355–365 million revenue and $0.68–0.70 EPS.
- The expanded Scorpio switch family — including the new 320‑lane Scorpio X-Series with hardware‑accelerated Hypercast and in‑network compute — is shipping initial volumes and is expected to ramp to production in H2 2026, positioning Scorpio to become the company’s largest product line.
- PCIe Gen 6 adoption is accelerating (Gen6 products drove over one‑third of revenue), advancing Aries/Taurus adoption and supporting management’s claim of increasing silicon dollar content to over $1,000 per XPU in AI racks.
- Astera is advancing its optical roadmap after the XSCALE/aiXscale integration, targeting volume shipments for near‑package optics and pluggable connector solutions starting in 2027, but these initiatives remain multi‑year with supply and qualification risks.
- Custom solutions and memory initiatives are progressing — the Leo CXL controller is on track with Microsoft Azure M‑series and Astera won a KV‑cache offload design win (shipments expected in 2027), with additional hyperscaler engagements for NVLink Fusion and other custom programs.
Astera Labs Stock Up 7.2%
Astera Labs stock traded up $14.44 during midday trading on Tuesday, reaching $215.69. The company’s stock had a trading volume of 7,992,940 shares, compared to its average volume of 5,897,388. Astera Labs has a fifty-two week low of $63.40 and a fifty-two week high of $262.90. The company has a market cap of $36.94 billion, a P/E ratio of 186.34, a P/E/G ratio of 3.96 and a beta of 3.35. The business has a 50-day simple moving average of $139.00 and a 200-day simple moving average of $153.00.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Analysis on ALAB
Astera Labs News Roundup
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Q1 beat — Astera reported EPS of $0.61 vs. $0.54 consensus and revenue of $308.36M vs. $292.19M expected; margin and ROE remain strong, signaling healthy profitability as AI-related product sales ramp. Astera Labs Q1 press release
- Positive Sentiment: Raised guidance — Management set Q2 FY2026 EPS guidance of $0.68–$0.70 (well above the ~$0.50 consensus) and revenue guidance of $355M–$365M (well above ~$310M consensus), suggesting accelerating demand and improved forward visibility. Astera Labs delivers hefty beat-and-raise first-quarter report
- Positive Sentiment: AI product catalyst — Astera began shipping the new Scorpio X‑Series 320‑lane smart fabric switch (and expanded Scorpio P‑Series PCIe‑6 switches) to hyperscalers, positioning the company to capture incrementally larger share of rack‑scale AI infrastructure spend. Astera Labs extends leadership with 320‑lane Scorpio X‑Series
- Positive Sentiment: Record revenue & management commentary — Company announced record Q1 revenue up 93% YoY and cited strong demand for PCIe‑6 AI fabric and signal conditioning products as core drivers. That supports the beat-and-raise narrative. Astera Labs reports first-quarter 2026 financial results
- Neutral Sentiment: Analyst sentiment — The stock carries an average rating of “Moderate Buy” from analysts, which supports continued investor interest but still implies analysts see upside with some caution. Astera Labs receives average rating of Moderate Buy
- Neutral Sentiment: Media mentions and momentum — High-profile bullish mentions (e.g., Jim Cramer recommending adding to a position) and a broader chip‑sector rally are amplifying investor interest; these drive sentiment but are less directly predictive of fundamentals. Jim Cramer bullish on Astera Labs
Insiders Place Their Bets
In other news, Director Stefan A. Dyckerhoff sold 3,757 shares of Astera Labs stock in a transaction dated Monday, April 20th. The stock was sold at an average price of $175.12, for a total transaction of $657,925.84. Following the sale, the director owned 67,144 shares in the company, valued at approximately $11,758,257.28. The trade was a 5.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total value of $19,692,630.00. Following the sale, the director owned 319,863 shares in the company, valued at $34,420,457.43. This trade represents a 36.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,064,888 shares of company stock valued at $150,764,723 in the last three months. Corporate insiders own 12.50% of the company’s stock.
Hedge Funds Weigh In On Astera Labs
A number of hedge funds and other institutional investors have recently made changes to their positions in ALAB. Amundi grew its holdings in shares of Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after buying an additional 1,319,643 shares during the last quarter. State Street Corp boosted its holdings in Astera Labs by 32.5% in the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after purchasing an additional 760,358 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in Astera Labs by 162.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,164,414 shares of the company’s stock valued at $193,713,000 after purchasing an additional 720,844 shares in the last quarter. Voloridge Investment Management LLC purchased a new stake in Astera Labs in the 3rd quarter valued at approximately $131,539,000. Finally, Holocene Advisors LP purchased a new stake in Astera Labs in the 2nd quarter valued at approximately $55,827,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Recommended Stories
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
